The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mikie: A randomized, double-blinded, regimen-controlled, phase 2 study to assess the efficacy and safety of two different vismodegib (VISMO) regimens in patients (pts) with multiple basal cell carcinomas (BCCs).
 
Gary Rogers
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech
Travel, Accommodations, Expenses - Genentech
 
Rainer Kunstfeld
Honoraria - Meda Pharmaceuticals; Menarini; Novartis; Roche
Consulting or Advisory Role - LEO Pharma; Meda Pharmaceuticals; Menarini; Novartis; Roche; Spring Bioscience
 
Dirk Schadendorf
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
 
Ian Maher
Research Funding - Genentech (Inst)
 
David Zloty
Honoraria - Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Roche
 
Bruno Labeille
No Relationships to Disclose
 
Jean Jacques Grob
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Speakers' Bureau - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Susana Puig
Honoraria - Bristol-Myers Squibb; ISDIN; La Roche-Posay; LEO Pharma; Meda; Merck; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; LEO Pharma; Novartis; Roche
Speakers' Bureau - Almirall Hermal GmbH; Bristol-Myers Squibb; ISDIN; La Roche-Posay; LEO Pharma; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; La Roche-Posay; LEO Pharma; Meda; Merck; Roche
 
Daniel Bergstrom
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Frank Gilberg
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Brigitte Dréno
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche